Momenta Pharmaceuticals, Inc. (MNTA): USPTO invalidates Teva's '302 patent on...

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Re: DewDiligence post# 15827

Thursday, 09/01/2016 2:50:01 PM

Thursday, September 01, 2016 2:50:01 PM

USPTO invalidates Teva's '302 patent on 40mg Copaxone:

down goes '302 $TEVA
— zach (@zbiotech) September 1, 2016

That makes 3 of 3 Teva patents invalidated by the PTO—the IPR; the other two are the '413 and '250 patents (#msg-124748552).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Replies (3) Next 10 Prev Next

Go Ad-Free